BAUDETTE, Minn., July 28, 2016 /PRNewswire/ -- ANI
Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the
Company plans to release its second quarter and year-to-date 2016
financial results on Thursday, August 4,
2016, before the opening of the U.S. financial markets. The
earnings press release will be accessible through the Investor
Relations section of the Company's website,
www.anipharmaceuticals.com.
Arthur S. Przybyl, President and
Chief Executive Officer, and Stephen P.
Carey, Vice President and Chief Financial Officer, also plan
to host a conference call to review those results starting at
10:30am Eastern Time on Thursday, August 4, 2016. The call will be open
to the public and can be accessed through a conference line by
dialing (866) 776-8875. The conference ID is 47510730.
A recording of the conference call will be available within two
hours of the completion of the call and will remain accessible for
a period of seven days following the call. To access the replay,
dial (800) 585-8367. The access code for the replay is
47510730.
About ANI
ANI Pharmaceuticals, Inc. (the "Company" or "ANI") is an
integrated specialty pharmaceutical company developing,
manufacturing, and marketing branded and generic prescription
pharmaceuticals. The Company's targeted areas of product
development currently include controlled substances, oncolytics
(anti-cancers), hormones and steroids, and complex formulations
involving extended release and combination products. For more
information, please visit our website
www.anipharmaceuticals.com.
For more information about ANI, please contact:
Investor Relations
IR@anipharmaceuticals.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/ani-pharmaceuticals-schedules-conference-call-to-discuss-second-quarter-and-year-to-date-2016-financial-results-300305205.html
SOURCE ANI Pharmaceuticals, Inc.